Your browser is no longer supported. Please, upgrade your browser.
Settings
FLDM Fluidigm Corporation daily Stock Chart
FLDM [NASD]
Fluidigm Corporation
Index- P/E- EPS (ttm)-2.23 Insider Own0.70% Shs Outstand39.77M Perf Week4.34%
Market Cap267.65M Forward P/E- EPS next Y-1.36 Insider Trans328.11% Shs Float38.27M Perf Month10.15%
Income-67.80M PEG- EPS next Q-0.39 Inst Own97.90% Short Float7.72% Perf Quarter45.04%
Sales99.30M P/S2.70 EPS this Y-36.40% Inst Trans0.02% Short Ratio12.00 Perf Half Y74.35%
Book/sh1.13 P/B5.96 EPS next Y32.30% ROA-23.20% Target Price5.83 Perf Year-11.10%
Cash/sh1.57 P/C4.30 EPS next 5Y-8.06% ROE-175.20% 52W Range2.52 - 7.71 Perf YTD14.26%
Dividend- P/FCF- EPS past 5Y-7.60% ROI-27.80% 52W High-16.47% Beta3.38
Dividend %- Quick Ratio2.50 Sales past 5Y19.50% Gross Margin51.90% 52W Low156.06% ATR0.42
Employees589 Current Ratio3.00 Sales Q/Q11.30% Oper. Margin-67.90% RSI (14)54.72 Volatility7.57% 7.26%
OptionableYes Debt/Eq4.99 EPS Q/Q32.10% Profit Margin-68.30% Rel Volume0.43 Prev Close6.73
ShortableYes LT Debt/Eq4.99 EarningsFeb 01 AMC Payout- Avg Volume246.15K Price6.44
Recom3.00 SMA201.49% SMA509.74% SMA20031.44% Volume106,934 Change-4.31%
Aug-05-16Reiterated Mizuho Buy $11 → $12
Aug-05-16Reiterated Cantor Fitzgerald Buy $13 → $11
May-05-16Reiterated Mizuho Buy $8 → $11
Apr-12-16Reiterated Leerink Partners Outperform $20 → $15
Jan-07-16Initiated Deutsche Bank Buy $18
Oct-30-15Upgrade Cantor Fitzgerald Hold → Buy $15 → $12
Oct-30-15Reiterated Mizuho Neutral $15 → $8
Aug-27-15Initiated Cantor Fitzgerald Hold
Aug-07-15Reiterated Mizuho Neutral $30 → $15
Aug-07-15Downgrade Piper Jaffray Overweight → Neutral
May-08-15Reiterated Maxim Group Buy $52 → $44
May-08-15Downgrade Mizuho Buy → Neutral $50 → $30
May-06-14Reiterated Maxim Group Buy $65 → $52
Apr-23-14Upgrade Mizuho Neutral → Buy $43 → $50
Mar-21-14Reiterated Maxim Group Buy $52 → $65
Feb-03-14Reiterated Oppenheimer Outperform $46 → $52
Jan-14-14Reiterated Mizuho Neutral $30 → $43
Dec-18-13Reiterated Maxim Group Buy $33 → $42
Oct-31-13Reiterated Mizuho Neutral $19 → $30
Oct-31-13Reiterated Maxim Group Buy $26 → $33
Jan-09-18 07:30AM  Detailed Research: Economic Perspectives on Fluidigm, Stemline Therapeutics, NeoGenomics, CVR Energy, W.R. Berkley, and Mack-Cali Realty What Drives Growth in Today's Competitive Landscape GlobeNewswire
Jan-01-18 11:35AM  ETFs with exposure to Fluidigm Corp. : January 1, 2018 Capital Cube
Dec-29-17 05:55PM  Was Fluidigm Corporations (NASDAQ:FLDM) Earnings Growth Better Than Industry? Simply Wall St.
Dec-21-17 04:05PM  Fluidigm Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
Dec-19-17 01:01PM  ETFs with exposure to Fluidigm Corp. : December 19, 2017 Capital Cube
Dec-07-17 01:44PM  ETFs with exposure to Fluidigm Corp. : December 7, 2017 Capital Cube
Nov-27-17 01:37PM  ETFs with exposure to Fluidigm Corp. : November 27, 2017 Capital Cube +6.08%
Nov-24-17 11:34PM  Edited Transcript of FLDM earnings conference call or presentation 2-Nov-17 9:00pm GMT Thomson Reuters StreetEvents
Nov-21-17 09:06AM  Fluidigm Corp. :FLDM-US: Earnings Analysis: Q3, 2017 By the Numbers : November 21, 2017 Capital Cube
Nov-14-17 04:05PM  Fluidigm to Participate in the 29th Annual Piper Jaffray Healthcare Conference GlobeNewswire +5.38%
Nov-02-17 06:19PM  Fluidigm reports 3Q loss Associated Press
04:05PM  Fluidigm Announces Third Quarter Financial Results and Operational Progress GlobeNewswire
12:30PM  Fluidigm Corporation to Host Earnings Call ACCESSWIRE
Oct-31-17 08:25PM  Does Fluidigm Corporations (FLDM) Debt Level Pose A Serious Problem? Simply Wall St.
Oct-25-17 09:58AM  ETFs with exposure to Fluidigm Corp. : October 25, 2017 Capital Cube
Oct-24-17 08:10AM  Fluidigm Announces Agreement With the University of Zurich to Distribute histoCAT for Multiparameter Imaging Mass Cytometry Data Analysis GlobeNewswire
08:00AM  Fluidigm Introduces Imaging Mass Cytometry System for Highly Multiplexed Protein Detection in Tissues GlobeNewswire
Oct-19-17 04:05PM  Fluidigm to Report Q3 2017 Financial Results and Host Conference Call GlobeNewswire
Oct-18-17 09:00AM  Fluidigm to Unveil High-Parameter Tissue Imaging System GlobeNewswire
Oct-11-17 11:31AM  ETFs with exposure to Fluidigm Corp. : October 11, 2017 Capital Cube
Sep-30-17 03:37PM  Should You Be Concerned About Fluidigm Corporations (FLDM) Risks? Simply Wall St.
Aug-28-17 04:05PM  Fluidigm to Participate in Two Upcoming Health Care Conferences in September GlobeNewswire
Aug-25-17 04:26PM  ETFs with exposure to Fluidigm Corp. : August 25, 2017 Capital Cube +14.99%
Aug-18-17 07:47AM  Fluidigm (FLDM) Licenses CFTR Assay From Baylor Genetics Zacks
Aug-17-17 04:05PM  Fluidigm Licenses CFTR Next-Generation Sequencing Assay From Baylor Genetics for Use With the Juno System GlobeNewswire
Aug-16-17 11:09AM  Fluidigm Corp. :FLDM-US: Earnings Analysis: Q2, 2017 By the Numbers : August 16, 2017 Capital Cube
Aug-11-17 06:50PM  Edited Transcript of FLDM earnings conference call or presentation 3-Aug-17 9:00pm GMT Thomson Reuters StreetEvents
Aug-10-17 07:20PM  Fluidigm Announces Sale of $30 Million of Common Stock in At-The-Market Equity Offering GlobeNewswire +5.96%
Aug-05-17 01:10AM  Fluidigm reports 2Q loss Associated Press
Aug-03-17 04:05PM  Fluidigm Announces Second Quarter Financial Results and Operational Progress GlobeNewswire
02:30PM  Investor Network: Fluidigm Corporation to Host Earnings Call ACCESSWIRE
Aug-02-17 06:00AM  Fluidigm Corporation Announces Termination of Tax Benefit Preservation Plan GlobeNewswire -5.25%
Jul-27-17 04:05PM  Fluidigm and Ascendas Genomics Announce Strategic Partnership to Develop Microfluidic Molecular Diagnostics in China GlobeNewswire
Jul-20-17 04:05PM  Fluidigm to Report Q2 2017 Financial Results and Host Conference Call GlobeNewswire
Jul-18-17 09:00AM  Fluidigm Introduces Immuno-Oncology Gene Expression Assay for Translational and Clinical Research GlobeNewswire -8.10%
Jul-10-17 02:29PM  ETFs with exposure to Fluidigm Corp. : July 10, 2017 Capital Cube
Jun-16-17 03:47PM  ETFs with exposure to Fluidigm Corp. : June 16, 2017 Capital Cube
Jun-02-17 02:08PM  ETFs with exposure to Fluidigm Corp. : June 2, 2017 Capital Cube
May-23-17 08:50PM  Edited Transcript of FLDM earnings conference call or presentation 4-May-17 9:00pm GMT Thomson Reuters StreetEvents -10.35%
May-15-17 03:44PM  ETFs with exposure to Fluidigm Corp. : May 15, 2017 Capital Cube
May-12-17 10:37AM  Fluidigm Corp. :FLDM-US: Earnings Analysis: Q1, 2017 By the Numbers : May 12, 2017 Capital Cube
May-10-17 08:40PM  Edited Transcript of FLDM earnings conference call or presentation 4-May-17 9:00pm GMT Thomson Reuters StreetEvents
May-05-17 05:02AM  Fluidigm reports 1Q loss Associated Press +17.53%
May-04-17 04:10PM  European Mass Cytometry Consortium Brings CyTOF Technology to Leading Universities to Advance Clinical Research GlobeNewswire
04:05PM  Fluidigm Announces First Quarter Financial Results GlobeNewswire
01:25PM  Investor Network: Fluidigm Corporation to Host Earnings Call Accesswire
Apr-28-17 06:54AM  Cerner (CERN) Earnings and Revenues Beat Estimates in Q1 Zacks
Apr-27-17 09:46AM  CONMED (CNMD) Q1 Earnings Surpass Estimates, Increase Y/Y Zacks
Apr-20-17 04:05PM  Fluidigm to Report Q1 2017 Financial Results and Host Conference Call GlobeNewswire
Apr-07-17 10:06AM  Becton (BDX) Gets FDA 510(k) for New Flow Cytometer System Zacks
09:49AM  Fresenius (FMS) Acquires 70% Stake in Kunming Wuhua Hospital Zacks
Apr-06-17 10:34AM  Mazor Expects Higher Q1 Revenue, Receives Mazor X Orders Zacks +8.04%
Apr-05-17 10:24AM  Teleflex (TFX) Acquires Medical Device Provider Pyng Medical Zacks
10:16AM  Becton, Dickinson Takes Over Caesarea Medical Electronics Zacks
Apr-03-17 10:13AM  Varian (VAR) Eclipse Software Tops in International Studies Zacks -7.56%
Mar-31-17 11:11AM  PAREXEL (PRXL) Launches Sensor for Clinical Trial Market Zacks
11:04AM  AngioDynamics (ANGO) Beats on Q3 Earnings, Raises 2017 View Zacks
Mar-30-17 11:14AM  Merit Medical (MMSI) Closes 5.2M Follow-On Share Offering Zacks
11:14AM  Merit Medical (MMSI) Closes 5.2M Follow-On Share Offering at Investopedia
11:11AM  Envision (EVHC) Teams Up with Lyft to Focus on Transportation Zacks
11:11AM  Envision (EVHC) Teams Up with Lyft to Focus on Transportation at Investopedia
08:56AM  Cerner (CERN) Banks on RCM & PH Platforms, Competition Rife Zacks
08:56AM  Cerner (CERN) Banks on RCM & PH Platforms, Competition Rife at Investopedia
Mar-29-17 09:30AM  Zacks.com featured highlights: United Bankshares, TopBuild, WSFS Financial, Fluidigm and Otter Tail Zacks
09:30AM  Zacks.com featured highlights: United Bankshares, TopBuild, WSFS Financial, Fluidigm and Otter Tail at Investopedia
09:04AM  Intuitive Surgical Hits 52-Week High on Multiple Positives
09:04AM  Intuitive Surgical Hits 52-Week High on Multiple Positives
08:32AM  Akers Receives Cholesterol Test Kit Order from First Check
Mar-28-17 09:39AM  Henry Schein (HSIC) Poised on Solid Growth, Risks Remain
09:29AM  BioScrip (BIOS) Stock Declines on Dull Q1 EBITDA Outlook
09:08AM  Evolent Health (EVH) Prices 7.5M Follow-On Share Offering
Mar-27-17 04:13PM  FLUIDIGM CORP Files SEC form 8-K, Change in Directors or Principal Officers
04:05PM  Nicolas Barthelemy and Carlos Paya Join Fluidigm Board of Directors GlobeNewswire
08:53AM  DexCom Gains as CMS Announces Criteria for G5 Mobile CGM
Mar-23-17 12:26PM  Merit Medical (MMSI) Prices 4.5M Follow-On Share Offering +5.14%
Mar-22-17 08:58AM  HealthEquity (HQY) Q4 Earnings and Revenues Beat Estimates
08:50AM  DENTSPLY Sirona Grapples with Multiple Issues: Dump Now?
08:32AM  Neogen (NEOG) Earnings and Revenues Meet Estimates in Q3
Mar-21-17 11:02AM  Merit Medical (MMSI) to Refinance Debt via Share Offering
Mar-20-17 09:11AM  Mazor Robotics-Medtronic's Mazor X Partnership Strengthens +5.44%
09:05AM  Fresenius (FMS) to Jointly Develop Acumen with Epic Systems
Mar-17-17 11:32AM  Fluidigm Corp. :FLDM-US: Earnings Analysis: Q4, 2016 By the Numbers : March 17, 2017
10:14AM  Air Methods (AIRM) Opens New Training Facility in Colorado
Mar-15-17 11:19AM  Patterson (PDCO) Rewards Shareholders with 8% Dividend Hike
11:10AM  Air Methods (AIRM) Set to be Acquired for $2.5 Billion
10:10AM  Stryker Launches MAKO Robotic-Arm for Knee Anthroplasty
Mar-13-17 09:30AM  ABIOMED Impella Heart Pump Reduces Kidney Injury during PCI
Mar-10-17 09:05AM  Cogentix (CGNT) Q4 Earnings and Revenues Miss Estimates
Mar-09-17 10:41AM  Cooper Companies (COO) Receives ISO 15189 Accreditation
10:40AM  C. R. Bard (BCR) Well Poised for Growth, Macro Woes Remain
Mar-08-17 01:04PM  FLUIDIGM CORP Financials -6.23%
Mar-07-17 10:51AM  TransEnterix (TRXC) Reports Wider-Than-Expected Loss in Q4 -7.77%
Mar-03-17 06:09AM  FLUIDIGM CORP Files SEC form 10-K, Annual Report -5.67%
Mar-02-17 04:26PM  FLUIDIGM CORP Files SEC form 8-K, Change in Directors or Principal Officers -6.62%
Mar-01-17 08:58AM  Inogen (INGN) Tops Earnings & Revenues in Q4; View Upbeat
07:58AM  Integer (ITGR) Beats Earnings and Revenue Estimates in Q4
Feb-28-17 01:30PM  Allscripts Launches Clinical Pathways for Cancer Treatment
Feb-23-17 04:05PM  Fluidigm to Present at Cowen and Company 37th Annual Health Care Conference GlobeNewswire
02:02PM  Patterson Companies (PDCO) Earnings Beat Estimates in Q3
10:04AM  Fresenius Medical (FMS) Tops Earnings in Q4, View Upbeat
Fluidigm Corporation creates, manufactures, and markets technologies and tools for life sciences research. It offers preparatory instruments, such as access array system, juno system, and callisto system; analytical instruments comprising biomark HD and EP1 systems; integrated fluidic circuits (IFCs) consisting of access array, juno genotyping, dynamic array, digital array, flex six, and callisto IFCs; and assays and reagents, including delta gene and SNP type assays, access array target-specific primers and targeted sequencing prep primers, and targeted DNA Seq library assays. The company also provides C1 single-cell systems, polaris systems, C1 IFCs, polaris IFCs, helios/CyTOF 2 systems, maxpar reagents, imaging mass cytometer instruments and reagents, and laser ablation modules. It serves academic institutions; clinical research laboratories; biopharmaceutical, biotechnology, and agricultural biotechnology companies; and contract research organizations. Fluidigm Corporation distributes its systems through direct sales force and support organizations located in North America, Europe, and the Asia-Pacific, and through distributors or sales agents in various European, Latin American, Middle Eastern, and the Asia-Pacific countries. The company was formerly known as Mycometrix Corporation and changed its name to Fluidigm Corporation in April 2001. Fluidigm Corporation was founded in 1999 and is headquartered in South San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorJan 10Buy6.1435,200215,99810,438,124Jan 11 08:46 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorJan 09Buy6.4565,376421,34810,438,053Jan 11 08:46 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorJan 04Buy6.69138710,379,900Jan 05 03:06 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorJan 03Buy6.632919210,379,887Jan 05 03:06 PM
Paya Carlos VDirectorDec 31Option Exercise0.003,64107,282Jan 03 04:51 PM
COLELLA SAMUEL DDirectorDec 31Option Exercise0.007,848059,093Jan 03 04:52 PM
Burbach Gerhard FDirectorDec 31Option Exercise0.005,259015,518Jan 03 04:52 PM
BARTHELEMY NICOLASDirectorDec 31Option Exercise0.004,611016,323Jan 03 04:52 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorDec 29Buy5.9411,20066,53410,379,858Jan 02 04:47 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorDec 28Buy5.82301751,181,375Jan 02 04:47 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorDec 27Buy5.8521,345124,96610,379,849Dec 28 03:42 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorDec 26Buy6.005,75534,50810,372,892Dec 28 03:42 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorDec 15Buy5.943,79522,53810,367,137Dec 18 06:48 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorDec 14Buy5.8220,380118,52410,363,342Dec 18 06:48 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorDec 12Buy5.8210,83863,09910,342,962Dec 13 07:27 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorDec 11Buy5.867,73145,31010,332,124Dec 13 07:27 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorDec 04Buy5.488,40946,04710,324,393Dec 06 12:45 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorNov 30Buy5.9576,629455,94310,315,984Dec 04 05:35 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorNov 29Buy5.5410,38057,53710,239,355Nov 30 05:11 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorNov 28Buy5.8810,00058,76810,234,686Nov 30 05:11 PM
LEE JENNIFER LINGSee RemarksNov 20Option Exercise0.001,75505,184Nov 22 09:02 PM
Yow Mai ChanSee RemarksNov 20Option Exercise0.002,393017,426Nov 22 09:00 PM
McPhail StevenChief Commercial OfficerNov 20Option Exercise0.002,397031,845Nov 22 09:01 PM
JOG VIKRAMCHIEF FINANCIAL OFFICERNov 20Option Exercise0.003,150012,625Nov 22 09:01 PM
Linthwaite Stephen ChristopherPresident & CEONov 20Option Exercise0.004,7500114,691Nov 22 09:01 PM
Khadder NicholasSee RemarksNov 20Option Exercise0.002,65007,379Nov 22 09:00 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorNov 17Buy5.056,88034,74410,224,686Nov 21 04:32 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorNov 09Buy5.1225,000127,97510,217,806Nov 13 06:59 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorNov 08Buy5.255,00026,25010,192,806Nov 09 02:57 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorNov 07Buy5.2649,900262,52410,187,806Nov 09 02:57 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorOct 25Buy5.424,22722,91710,460,407Oct 27 04:35 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorOct 23Buy5.4722,363122,30510,456,180Oct 24 03:56 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorOct 19Buy4.5560,000273,00010,433,817Oct 23 04:58 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorOct 17Buy4.6591,600425,94010,373,817Oct 23 11:30 AM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorOct 16Buy4.5052,600236,55810,282,217Oct 23 11:30 AM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorOct 10Buy4.5545,843208,56310,229,617Oct 11 05:16 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorOct 09Buy4.5950,000229,43510,183,774Oct 11 05:16 PM
COLELLA SAMUEL DDirectorSep 30Option Exercise0.007,848053,045Oct 02 08:56 PM
Paya Carlos VDirectorSep 30Option Exercise0.003,64103,641Oct 02 08:55 PM
BARTHELEMY NICOLASDirectorSep 30Option Exercise0.004,612011,712Oct 02 08:55 PM
Burbach Gerhard FDirectorSep 30Option Exercise0.005,259010,259Oct 02 08:55 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorSep 12Buy5.2560,000314,70010,134,731Sep 14 04:40 PM
LEE JENNIFER LINGSee RemarksAug 21Option Exercise0.001,75504,089Aug 23 05:06 PM
Linthwaite Stephen ChristopherPresident & CEOAug 21Option Exercise0.004,7500111,727Aug 23 05:07 PM
Khadder NicholasSee RemarksAug 21Option Exercise0.005,12506,656Aug 23 05:05 PM
Yow Mai ChanSee RemarksAug 21Option Exercise0.002,395015,033Aug 23 05:06 PM
McPhail StevenChief Commercial OfficerAug 21Option Exercise0.002,397030,239Aug 23 05:06 PM
JOG VIKRAMCHIEF FINANCIAL OFFICERAug 21Option Exercise0.003,150010,661Aug 23 05:06 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorAug 17Buy3.664651,70110,122,581Aug 18 02:13 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorAug 09Buy3.181,5494,9326,334,209Aug 11 04:39 PM
Linthwaite Stephen ChristopherPresident & CEOAug 08Buy2.6645,000119,885106,977Aug 08 08:35 PM
JOG VIKRAMCHIEF FINANCIAL OFFICERAug 08Buy2.7150,000135,30552,061Aug 08 08:33 PM
COLELLA SAMUEL DDirectorAug 08Buy2.7735,89599,35753,395Aug 08 08:30 PM
McPhail StevenChief Commercial OfficerAug 08Buy3.0020,00060,03227,842Aug 08 08:29 PM
COLELLA SAMUEL DDirectorJul 31Option Exercise0.005,000045,197Aug 02 08:39 PM
YOUNG JOHN ADirectorJul 31Option Exercise0.005,00005,849Aug 02 08:35 PM
JONES PATRICK SDirectorJul 31Option Exercise0.005,00005,000Aug 02 08:36 PM
JONES EVAN/ FADirectorJul 31Option Exercise0.005,000058,551Aug 02 08:34 PM
Burbach Gerhard FDirectorJul 31Option Exercise0.005,00005,000Aug 02 08:33 PM
JONES EVAN/ FADirectorJun 07Sale4.411,4006,16753,551Jun 08 07:31 PM
JONES EVAN/ FADirectorJun 06Sale4.569,50043,34454,951Jun 08 07:31 PM
Linthwaite Stephen ChristopherPresident & CEOMay 22Option Exercise0.006,333064,333May 23 06:59 PM
JOG VIKRAMCHIEF FINANCIAL OFFICERMay 22Option Exercise0.003,87008,933May 23 06:58 PM
LEE JENNIFER LINGSee RemarksMay 22Option Exercise0.004,01904,019May 23 06:57 PM
Khadder NicholasSee RemarksMay 22Option Exercise0.002,63302,633May 23 06:55 PM
McPhail StevenChief Commercial OfficerMay 22Option Exercise0.002,82408,749May 23 06:53 PM
Yow Mai ChanSee RemarksMay 22Option Exercise0.002,798012,638May 23 06:52 PM
COLELLA SAMUEL DDirectorMay 09Buy5.937,50044,43817,500May 11 06:08 PM
COLELLA SAMUEL DDirectorMar 14Buy5.0010,00049,97310,000Mar 15 02:24 PM